The much-awaited U.S. job market report is finally out for May, and while the result was stronger than expected, the headline number may not tell the whole story. The economy added 172,000 jobs last month, Read more…
Nothing about the 2026 housing market has gone quite like we’ve expected, has it? In its December 2025 Housing Forecast, Fannie Mae predicted that the 30-year mortgage rate would stay in the low-6% range for Read more…
Micron Technology (MU) is suddenly one of Wall Street’s most dramatic artificial intelligence stories. The chipmaker, formerly seen as a cyclical memory business, was the kind of stock that would climb higher as DRAM and Read more…
Imagine coming home from work and realizing that your phone no longer works because your internet service has gone down. Most people would not be overly concerned because every Internet Service Provider (ISP) has temporary Read more…
TheStreet aims to feature only the best products and services. If you buy something via one of our links, we may earn a commission. Elevating your living room doesn’t always mean getting a brand new Read more…
Consumers expect it. Bond traders dread it. And analysts are watching it all very closely. Rising prices are driving higher inflation anxiety for Americans even as the labor market seems to stabilize. All of which Read more…
Transcript: Caroline WoodsSpaceX is expected to go public this week. Anthropic is waiting in the wings. OpenAI could be next. Some are calling this the biggest IPO wave of our lifetime. But for the average Read more…
During this week of trading, with the heated anticipation of the SpaceX initial public offering (IPO), it’s particularly important for investors to remember the Facebook IPO. Investors were clamoring. It was the biggest event on Read more…
When a Wall Street heavyweight tells you a $1.8 trillion company still looks cheap, it’s worth slowing down to understand why. That’s roughly the message coming out of JPMorgan (JPM) this month. Fresh off Broadcom’s Read more…
Mark Cuban has spent years criticizing American healthcare from the outside. Then he built a drug company, Cost Plus Drugs, to prove his point. Then he wrote a blog post that went viral among healthcare Read more…